Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 5 pseudogene 3 (SLC25A5P3)
- Target
- SLC25A5P3
- Molecular classification
- Other (pseudogene)
01
Overview
SLC25A5P3 (solute carrier family 25 member 5 pseudogene 3) is a processed pseudogene in the human genome, meaning it is a DNA segment similar to the gene encoding adenine nucleotide translocator (SLC25A5), a mitochondrial carrier, but does not produce a functional protein. Pseudogenes like SLC25A5P3 are generally considered nonfunctional but may occasionally play regulatory roles at the RNA level; for this particular locus, there is no direct evidence of disease relevance or regulatory significance. The pseudogene is not considered a therapeutic or functional molecular target.
- Other names
- ANTP1
02
Mechanism of action
None reported (not a therapeutic or drug-interacting target).
03
Biological functions
Current evidence indicates no direct protein-coding or classical biological function; however, pseudogenes can sometimes play regulatory RNA roles, such as acting as microRNA decoys or regulators of their parent gene expression, though there is no specific evidence for SLC25A5P3 itself
04
Disease associations
None known directly. Some pseudogenes have been linked to disease through regulatory roles, but SLC25A5P3 is not specifically mentioned in major studies of disease-associated pseudogenes
05
Safety considerations
None specific, as it is not targeted therapeutically or associated with adverse biological activity.
06
Interacting drugs
None reported. Pseudogenes typically do not encode druggable proteins.
07
Biomarkers
None reported specifically for patient selection or monitoring related to SLC25A5P3.
Beyond the preview
Go deeper on Solute carrier family 25 member 5 pseudogene 3 (SLC25A5P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solute carrier family 25 member 5 pseudogene 3 (SLC25A5P3).